Ann Gidner

Partner at Acel Partners + CEO at AGIRIS AB at Axcel Partners

Speaker

Ms Gidner is a Partner of the boutique management bureau Axcel Partners in Paris, France, as well as CEO of AGIRIS AB in Lund, and Board Director at Thor Medical in Norway. With 25+ years in international leadership roles in pharmaceutical industry, she has significant achievements in strategic development and sales growth, repeatedly building new Life Science businesses. Generating steep sales growth, designing and implementing new business models in global Pharma CDMO corporations, took her to Corporate Executive roles in New Jersey, US and Leverkusen, Germany for Cambrex Corp and Lanxess Corp. She built Pharma HLE technology out-licencing internationally for Novozymes Biopharma, Denmark and managed a Clinical Trial Business Unit in Berlin, Germany. In recent years she has been holding CEO and Board Director positions in publicly listed Swedish Biotech companies including SenzaGen AB, Iconovo AB, SelectImmune Pharma AB, AcuCort AB and Ziccum AB. Ms Gidner holds a MSc/Biotechnology from Swedish Lund Institute of Technology, a MSc/Bioprocédé from the French Elite University ENSIGC, as well as an MBA/Strategy from Swedish Lund University.